Search hospitals > Oregon > Portland

Kaiser Permanente Northwest

Claim this profile
Portland, Oregon 97227
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
135 reported clinical trials
3 medical researchers
Photo of Kaiser Permanente Northwest in PortlandPhoto of Kaiser Permanente Northwest in PortlandPhoto of Kaiser Permanente Northwest in Portland

Summary

Kaiser Permanente Northwest is a medical facility located in Portland, Oregon. This center is recognized for care of Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Breast cancer and other specialties. Kaiser Permanente Northwest is involved with conducting 135 clinical trials across 322 conditions. There are 3 research doctors associated with this hospital, such as Abdul Hai Mansoor, Sandeep Mashru, and Gloria Coronado.

Area of expertise

1Skin Cancer
Global Leader
Kaiser Permanente Northwest has run 42 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Lung Cancer
Global Leader
Kaiser Permanente Northwest has run 30 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III

Top PIs

Clinical Trials running at Kaiser Permanente Northwest

Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Breast cancer
Multiple Myeloma
Pancreatic Cancer
Skin Cancer
Prostate Cancer
Follicular Lymphoma
Kidney Cancer
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Targeted Therapy Screening

for Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Kaiser Permanente Northwest?
Kaiser Permanente Northwest is a medical facility located in Portland, Oregon. This center is recognized for care of Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Breast cancer and other specialties. Kaiser Permanente Northwest is involved with conducting 135 clinical trials across 322 conditions. There are 3 research doctors associated with this hospital, such as Abdul Hai Mansoor, Sandeep Mashru, and Gloria Coronado.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security